TRANSGENE BIOTEK
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Transgene Biotek along with daily highs, lows, percentage changes and volume trends, and, all financial information.
9.79₹ 0.37
As on Sep 15, 2025, 4:01 PM IST
Transgene Biotek Price Performance
Today's LowToday's High
₹3.55₹4.15
₹4.15
52 Weeks' Low52 Weeks' High
₹3.22₹8.55
₹4.15
Open Price
₹3.55
Prev. Close
₹3.78
Volume
95,787
Over the last 5 years, the share price of Transgene Biotek has declined 2.75% CAGR. Over the past year, the corresponding return has been -47.27%.
Transgene Biotek’s current P/E of -24.13x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Transgene Biotek Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Transgene Biotek | 12.47 | -6.32 | -2.35 | 8.07 | -49.27 | 7.72 | -2.75 |
| Sun Pharmaceutical Industries | 0.46 | -1.83 | -4.93 | -6.07 | -13.98 | 21.68 | 26.44 |
| Divi's Laboratories | 0.68 | -2.03 | -9.69 | 6.55 | 10.26 | 18.00 | 13.79 |
| Cipla | -0.18 | -0.98 | 1.45 | 3.75 | -6.67 | 13.52 | 16.50 |
| Torrent Pharmaceuticals | -3.05 | -3.34 | 7.71 | 15.39 | 2.27 | 32.67 | 20.35 |
| Dr. Reddy's Laboratories | 0.65 | 3.01 | -3.33 | 13.16 | -2.09 | 15.26 | 8.32 |
| Mankind Pharma | -0.41 | 4.42 | 8.91 | 18.73 | 4.99 | 21.89 | 12.61 |
| Zydus Lifesciences | 0 | 5.08 | 6.44 | 16.05 | -7.08 | 40.26 | 22.98 |
| Lupin | 4.49 | 3.93 | 1.81 | 2.80 | -9.12 | 44.83 | 16.16 |
| Abbott India | 1.08 | -5.07 | -2.16 | 2.66 | 6.29 | 19.99 | 13.39 |
| Alkem Laboratories | 3.00 | 2.66 | 12.83 | 14.01 | -13.62 | 19.58 | 13.54 |
| Aurobindo Pharma | 5.23 | 0.79 | -3.96 | -1.28 | -29.67 | 25.72 | 6.67 |
| Glenmark Pharmaceuticals | -0.85 | 6.28 | 24.71 | 46.64 | 20.47 | 74.71 | 34.18 |
| Laurus Labs | -0.70 | 3.54 | 31.78 | 54.09 | 77.57 | 17.47 | 27.44 |
| Biocon | -1.70 | -1.58 | 0.32 | 7.35 | -8.27 | 5.74 | -3.58 |
| Anthem Biosciences | 1.94 | 4.25 | 14.29 | 14.29 | 14.29 | 4.55 | 2.71 |
| GlaxoSmithKline Pharmaceuticals | -2.35 | -1.35 | -18.25 | 2.21 | -2.76 | 24.76 | 9.75 |
| Cohance Lifesciences | -3.42 | 9.49 | -0.98 | -13.33 | -15.99 | 26.86 | 22.11 |
| Ipca Laboratories | -0.43 | -5.15 | -3.58 | -0.16 | -9.98 | 13.54 | 4.09 |
| Gland Pharma | 4.52 | 1.75 | 13.40 | 29.15 | 7.54 | -6.26 | 1.96 |
Over the last one year, Transgene Biotek has declined 49.27% compared to peers like Sun Pharmaceutical Industries (-13.98%), Divi's Laboratories (10.26%), Cipla (-6.67%). From a 5 year perspective, Transgene Biotek has underperformed peers relative to Sun Pharmaceutical Industries (26.44%) and Divi's Laboratories (13.79%).
Transgene Biotek Financials
Transgene Biotek Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 3.85 | 3.81 |
| 10 | 3.87 | 3.88 |
| 20 | 4.08 | 4.04 |
| 50 | 4.52 | 4.27 |
| 100 | 4.29 | 4.39 |
| 200 | 4.64 | 4.86 |
Transgene Biotek Share Holding Pattern
In the latest quarter, Transgene Biotek remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 76.37% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Transgene Biotek Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 09, 2025, 12:08 AM IST | Transgene Biotek - Intimation Extension Of Time For Holding Annual General Meeting Of The Company For The Financial Year Ende |
| Sep 02, 2025, 3:42 AM IST | Transgene Biotek - Subject: Intimation About The Initiation Of Insolvency Process.This Is To Inform About The Receipt |
| Aug 07, 2025, 5:22 PM IST | Transgene Biotek - Board Meeting Outcome for Outcome Of The Board Meeting |
| Aug 07, 2025, 5:42 AM IST | Transgene Biotek - The Board Considered And Approved The Unaudited Financial Results (Standalone & Consolidated) Of The Compa |
| Jul 31, 2025, 12:06 AM IST | Transgene Biotek - Board Meeting Intimation for This Is To Inform You That A Meeting Of Board Of Directors Will Be Held On Th |
About Transgene Biotek
Transgene Biotek Ltd. is a Public Limited Listed company incorporated on 01/03/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85195TG1990PLC011065 and registration number is 011065. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 0.26 Cr. and Equity Capital is Rs. 75.77 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot Nos. 69 & 70, Anrich Industrial Area, Sangareddy Dist. Telangana 502325
- Contact
Management
- Dr. K Koteswara RaoChairman & Managing Director
- Mrs. Sujana KadiamDirector
- Mrs. Swetha MarriDirector
- Mr. Santosh KumarDirector
FAQs on Transgene Biotek Share Price
What is the share price of Transgene Biotek?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Transgene Biotek is ₹4.15 as on Sep 15, 2025.
What kind of stock is Transgene Biotek?
The Transgene Biotek is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Transgene Biotek?
The market cap of Transgene Biotek is ₹31.44 Cr as on Sep 15, 2025.
What are today's High and Low prices of Transgene Biotek?
Today’s highest and lowest price of Transgene Biotek are ₹4.15 and ₹3.55.
What are the 52 Week High and 52 Week Low of Transgene Biotek?
The 52-week high/low is the highest and lowest price at which Transgene Biotek stock has traded in the past 52-week or nearly a year. The 52-week high of Transgene Biotek is ₹8.55 and 52-week low of Transgene Biotek is ₹3.22 as on Sep 15, 2025.
How has the Transgene Biotek performed historically in terms of returns?
The Transgene Biotek has shown returns of 9.79% over the past day, -3.94% for the past month, -2.35% over 3 months, -47.27% over 1 year, 7.72% across 3 years, and -2.75% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Transgene Biotek?
P/E ratio of and PB ratio of Transgene Biotek are -24.13 and 2.90 on Sep 15, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data